HILPDA and hepatocellular carcinoma: Using bioinformatics, we discovered that the overall and disease-free survival rates of HCC patients with high expression of HIG2 were significantly lower than those of HCC patients with low expression of HIG2, indicating that the expression level of HIG2 is of clinical significance for the prognosis of HCC patients.